Pertussis is an endemic disease in the EU/EEA and worldwide. Every three to five years, larger epidemics are expected even with high vaccination coverage.
In 2019, the hajj will take place between 9 and 14 August. The risk for EU/EEA citizens to become infected with communicable diseases during the 2019 hajj is considered low, thanks to the vaccination requirements for travelling to Makkah (Mecca) and the Saudi Arabian preparedness plans that address the management of health hazards during and after hajj.
Since 23 August 2017 Madagascar has been experiencing an outbreak of plague, and as of 3 October 2017, 194 cases and 30 deaths (case fatality rate 15.5%) have been reported.
Madagascar has been experiencing an outbreak of plague since 23 August 2017, and 560 cases and 57 deaths (case fatality rate 10.1%) have been reported as of 12 October 2017.
Illnesses caused by infectious diseases are common in children in schools or other childcare settings. Currently there is no common EU approach to the control of communicable diseases in schools or other childcare settings, and existing information is uncertain.
This Rapid Risk Assessment focuses on acellular pertussis-containing combination vaccines used in national vaccination programmes in the EU/EEA Member States.
Early in 2015, a shortage of acellular pertussis-containing vaccines was brought to the attention of ECDC. This risk assessment provides a detailed list of mitigation options available to Member States.
This rapid risk assessment considers the risk to the EU of an outbreak of invasive meningococcal disease in the UK and Sweden associated with the 23rd World Scout Jamboree in Japan.
This rapid risk assessment provides a series of conclusions and recommendations based on the analysis of several European cases of invasive meningococcal disease among men who have sex with men caused by N. meningitidis serogroup C.